QuiVad

Home / United Kingdom / GW Pharmaceuticals PLC

GW Pharmaceuticals PLC

No short position is open on this share today.

Follow

Evolution of the disclosed total

0%1%
Oct 2025Jan 2026Apr 2026Jul 2026
Sum of open short positions, asĀ % of capital. Hover or tap the curve to see which funds make it up.
The whole history, peaking at 5.93% on August 1, 2014. The shaded band is the year shown above.

April 25, 2014 today

Open positions

No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.

Follow by RSS

Get the moves on GW Pharmaceuticals PLC by mail.

No account: one address, one link to confirm, one link to stop in every message.

History of disclosures

470 disclosures on record for this share.
DateFund% of capitalEnd of publication
February 11, 2020Healthcor Management, L.P.0.39%
January 13, 2020Healthcor Management, L.P.0.50%
December 1, 2017Numeric Investors LLC1.87%December 1, 2017
November 21, 2017HBK Investments L.P.0.21%
November 14, 2017HBK Investments L.P.0.53%
September 13, 2017Numeric Investors LLC1.25%
September 11, 2017Numeric Investors LLC1.34%
July 10, 2017Numeric Investors LLC0.99%
July 7, 2017Numeric Investors LLC1.00%
March 22, 2017Numeric Investors LLC1.49%
March 20, 2017Numeric Investors LLC1.58%
March 16, 2017Numeric Investors LLC1.47%
March 6, 2017Numeric Investors LLC1.57%
March 3, 2017Numeric Investors LLC1.60%
March 1, 2017Numeric Investors LLC1.45%
February 27, 2017Numeric Investors LLC1.22%
February 24, 2017Numeric Investors LLC1.06%
February 22, 2017Numeric Investors LLC0.98%
February 13, 2017Numeric Investors LLC1.00%
February 10, 2017Numeric Investors LLC0.93%
February 9, 2017Numeric Investors LLC0.76%
December 5, 2016Slate Path Capital LP0.00%
December 2, 2016Marshall Wace LLP1.80%December 2, 2016
November 29, 2016Marshall Wace LLP1.77%
November 28, 2016Discovery Capital Management, LLC0.99%November 28, 2016
November 25, 2016Marshall Wace LLP1.87%
November 22, 2016PDT Partners, LLC0.55%November 22, 2016
November 21, 2016Marshall Wace LLP1.93%
November 21, 2016PDT Partners, LLC0.49%
November 18, 2016Marshall Wace LLP1.89%
November 18, 2016Discovery Capital Management, LLC0.65%
November 18, 2016PDT Partners, LLC0.54%
November 17, 2016PDT Partners, LLC0.48%
November 17, 2016City Financial Investment Company Limited0.47%
November 16, 2016Marshall Wace LLP1.99%
November 10, 2016PDT Partners, LLC0.50%
November 8, 2016Slate Path Capital LP0.95%
November 7, 2016Slate Path Capital LP0.77%
November 7, 2016D. E. Shaw & CO. LP0.42%
November 4, 2016D. E. Shaw & CO. LP0.55%
November 3, 2016Marshall Wace LLP2.00%
November 2, 2016Marshall Wace LLP1.99%
November 2, 2016D. E. Shaw & CO. LP0.61%
October 27, 2016D. E. Shaw & CO. LP0.77%
October 26, 2016D. E. Shaw & CO. LP0.80%
October 24, 2016Worldquant LLC0.49%
October 20, 2016D. E. Shaw & CO. LP0.78%
October 12, 2016Worldquant LLC0.50%
October 12, 2016PDT Partners, LLC0.49%
October 11, 2016D. E. Shaw & CO. LP0.81%

Download 470 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in the United Kingdom

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, GW Pharmaceuticals PLC, source FCA, data as at February 11, 2020, https://www.quivad.com/action/gw-pharmaceuticals-plc